1. L. Aguirre-Cruz, J. L. Charuel, A. F. Carpentier, B. Benyahia, J. Y. Delattre, and L. Musset. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases. J Neurooncol, 71(1):39-41, 2005. Note: Clinical TrialComparative StudyJournal ArticleNetherlands. [WWW] Keyword(s): Aged, Antibodies, Antinuclear/*immunology, Autoantibodies/*immunology, Breast Neoplasms/immunology, Carcinoma, Small Cell/immunology, DNA-Binding Proteins/*immunology, Female, Hu Paraneoplastic Encephalomyelitis Antigens, Humans, Lung Neoplasms/immunology, Male, Middle Aged, Neoplasm Proteins/*immunology, Neoplasms/*immunology, Nerve Tissue Proteins/*immunology, Neurons/immunology, Ovarian Neoplasms/immunology, Paraneoplastic Syndromes, Nervous System/*immunology, Prostatic Neoplasms/immunology, RNA-Binding Proteins/*immunology, Urologic Neoplasms/immunology.



2. K. Mokhtari, S. Paris, L. Aguirre-Cruz, N. Privat, E. Criniere, Y. Marie, J. J. Hauw, M. Kujas, D. Rowitch, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol Appl Neurobiol, 31(1):62-9, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Basic Helix-Loop-Helix Transcription Factors, Brain Neoplasms/*classification/metabolism/pathology, Chromosomes, Human, Pair 1, Glial Fibrillary Acidic Protein/*metabolism, Glioma/*classification/metabolism/pathology, Humans, Immunohistochemistry, Loss of Heterozygosity, Nerve Tissue Proteins/*metabolism, Tumor Suppressor Protein p53/*metabolism.



3. L. Aguirre-Cruz, K. Mokhtari, K. Hoang-Xuan, Y. Marie, E. Criniere, S. Taillibert, M. Lopes, J. Y. Delattre, and M. Sanson. Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors. J Neurooncol, 67(3):265-71, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Astrocytes/metabolism, Basic Helix-Loop-Helix Transcription Factors, Brain Neoplasms/genetics/*metabolism/pathology, DNA Probes, DNA-Binding Proteins/genetics/*metabolism, Helix-Loop-Helix Motifs, Humans, In Situ Hybridization, Nerve Tissue Proteins/genetics/*metabolism, Neurons/metabolism, Oligodendroglia/metabolism.



4. C. Dichamp, S. Taillibert, L. Aguirre-Cruz, J. Lejeune, Y. Marie, M. Kujas, J. Y. Delattre, K. Hoang-Xuan, and M. Sanson. Loss of 14q chromosome in oligodendroglial and astrocytic tumors. J Neurooncol, 67(3):281-5, 2004. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Astrocytoma/*genetics/pathology, Brain Neoplasms/*genetics/pathology, Chromosomes, Human, Pair 14/*genetics, DNA, Neoplasm/genetics, Genes, erbB-1/genetics, Genes, p16/physiology, Genes, p53/genetics, Humans, *Loss of Heterozygosity, Microsatellite Repeats, Neoplasm Staging, Oligodendroglioma/*genetics/pathology, Phosphoric Monoester Hydrolases/genetics, Survival Rate.



5. P. Leuraud, E. Dezamis, L. Aguirre-Cruz, S. Taillibert, J. Lejeune, E. Robin, K. Mokhtari, A. L. Boch, P. Cornu, J. Y. Delattre, and M. Sanson. Prognostic value of allelic losses and telomerase activity in meningiomas. J Neurosurg, 100(2):303-9, 2004. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Chromosome Mapping, Disease Progression, Female, Humans, Loss of Heterozygosity/*genetics, Male, Meningeal Neoplasms/*genetics, Meningioma/*genetics, Middle Aged, Neoplasm Recurrence, Local/*genetics, Predictive Value of Tests, Prognosis, Telomerase/*genetics/physiology.



6. P. Leuraud, L. Taillandier, J. Medioni, L. Aguirre-Cruz, E. Criniere, Y. Marie, M. Kujas, J. L. Golmard, A. Duprez, J. Y. Delattre, M. Sanson, and M. F. Poupon. Distinct responses of xenografted gliomas to different alkylating agents are related to histology and genetic alterations. Cancer Res, 64(13):4648-53, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Animals, Antineoplastic Agents, Alkylating/*pharmacology, Carboplatin/pharmacology, Carmustine/pharmacology, *Chromosome Aberrations, Dacarbazine/*analogs & derivatives/pharmacology, Glioblastoma/*drug therapy/*genetics/pathology, Humans, Ifosfamide/pharmacology, Loss of Heterozygosity, Mice, Mice, Nude, Mutation, Oligodendroglioma/*drug therapy/*genetics/pathology, Xenograft Model Antitumor Assays.



7. O. Trouillard, L. Aguirre-Cruz, K. Hoang-Xuan, Y. Marie, J. Y. Delattre, and M. Sanson. Parental 19q loss and PEG3 expression in oligodendrogliomas. Cancer Genet Cytogenet, 151(2):182-3, 2004. Note: LetterResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Brain Neoplasms/*genetics, *Chromosome Deletion, *Chromosomes, Human, Pair 19, *Genomic Imprinting, Humans, Oligodendroglioma/*genetics, *Protein Kinases, Proteins/*genetics, *Transcription Factors.



8. P. Leuraud, L. Aguirre-Cruz, K. Hoang-Xuan, E. Criniere, M. L. Tanguy, J. L. Golmard, M. Kujas, J. Y. Delattre, and M. Sanson. Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1. Neurology, 60(11):1820-2, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Chromosome Mapping, *Chromosomes, Human, Pair 10, Glioma/enzymology/*genetics, Humans, *Loss of Heterozygosity, Telomerase/*metabolism.



9. P. Leuraud, L. Taillandier, L. Aguirre-Cruz, J. Medioni, E. Criniere, Y. Marie, A. M. Dutrillaux, M. Kujas, A. Duprez, J. Y. Delattre, M. F. Poupon, and M. Sanson. Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice. Br J Cancer, 89(12):2327-32, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Adult, Aged, Animals, Cell Division/*genetics, Central Nervous System Neoplasms/*genetics/*pathology, Female, Genes, Tumor Suppressor/physiology, Genes, erbB-1/genetics, Genes, p53/genetics, Glioma/*genetics/*pathology, Humans, Loss of Heterozygosity/genetics, Male, Mice, Mice, Nude, Middle Aged, *Models, Animal, Mutation/*genetics, Neoplasm Transplantation, PTEN Phosphohydrolase, Phosphoric Monoester Hydrolases/genetics, Proto-Oncogenes/genetics, Telomerase/genetics, Tumor Suppressor Proteins/genetics.



10. M. Sanson, L. Aguirre-Cruz, S. Cartalat-Carel, and K. Hoang-Xuan. Oligodendrogliomas: an update on basic and clinical research. Curr Neurol Neurosci Rep, 3(3):223-8, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tReviewUnited States. [WWW] Keyword(s): Animals, Biomedical Research, Brain Neoplasms/classification/*genetics/therapy, Chromosomes, Human, Pair 1/genetics, Chromosomes, Human, Pair 19, Gene Expression Regulation, Neoplastic/*genetics, Humans, Loss of Heterozygosity/genetics, Oligodendroglioma/classification/*genetics/therapy, *Tumor Markers, Biological/analysis.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html